SCHEMBL4657348

SCHEMBL4657348

COc1c(Cl)ccc(O)c1-c1c(O)ccc(Cl)c1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
HSD17B10 Q99714 3/20 0.48
KDM4E B2RXH2 1/20 0.48
CYP3A4 P08684 2/20 0.41
MAPK1 P28482 1/20 0.41
TPMT P51580 1/20 0.40
TSHR P16473 3/20 0.40
TDP1 Q9NUW8 2/20 0.39
MGAM O43451 2/20 0.39
GAA P10253 2/20 0.39
SI P14410 2/20 0.39
MGAM2 Q2M2H8 2/20 0.39
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
TAS1R3 Q7RTX0 2/20 0.36
TAS1R1 Q7RTX1 2/20 0.36
MAOB P27338 1/20 0.35
HIF1A Q16665 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14031971 0.90 ALDH1A1 (0.42) ALDH1A1HSD17B10KDM4ECYP3A4MAPK1
SCHEMBL28999634 0.85 PDE4B (0.55) ALDH1A1HSD17B10KDM4ETPMTTSHR
SCHEMBL17744214 0.84 ALDH1A1 (0.50) ALDH1A1HSD17B10KDM4ECYP3A4MAPK1
SCHEMBL11760316 0.82 ALDH1A1 (0.48) ALDH1A1HSD17B10KDM4ECYP3A4MAPK1
SCHEMBL5992537 0.77 CYP3A4 (0.52) ALDH1A1HSD17B10KDM4ECYP3A4MAPK1
SCHEMBL9332617 0.76 ALDH1A1 (0.52) ALDH1A1HSD17B10KDM4ECYP3A4MAPK1
SCHEMBL4842699 0.74 ALDH1A1 (0.45) ALDH1A1HSD17B10KDM4EMAPK1TSHR
SCHEMBL4255276 0.74 ALDH1A1 (0.59) ALDH1A1HSD17B10KDM4ECYP3A4MAPK1
SCHEMBL10920936 0.74 ALDH1A1 (0.46) ALDH1A1HSD17B10KDM4ETPMTTSHR
SCHEMBL2094518 0.73 CA1 (0.52) ALDH1A1HSD17B10KDM4ECYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1186609-B1 Diphosphines SALTIGO GMBH (DE) 2008-12-03 EP disclosed
US-6844462-B2 Reacting phenol with an alkali metal hydride, etherification, cyclization, decyclization, hydroxylation, phosphorylation; forming a chemical intermediates for phosphine catalyst BAYER AKTIENGESELLSCHAFT (DE) 2005-01-18 US disclosed
US-20030181736-A1 Diphosphines LANXESS DEUTSCHLAND GMBH (DE) 2003-09-25 US disclosed
US-6566298-B2 For use as catalysts BAYER AKTIENGESELLSCHAFT (DE) 2003-05-20 US disclosed
US-20030045713-A1 Diphosphines LANXESS DEUTSCHLAND GMBH (DE) 2003-03-06 US disclosed
US-6462200-B2 CONVERTING A PHENOL INTO THE CORRESPONDING PHENOXIDE USING A BASE, REACTING THE PHENOXIDE WITH DIHALOGENOMETHANE TO GIVE A FORMALDEHYDE ACETAL, INTRAMOLECULARLY OXIDATIVELY COUPLING THE FORMALDEHYDE ACETAL TO GIVE A CYCLOHEPTADIENE BAYER AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
US-20020055653-A1 Converting a phenol into the corresponding phenoxide using a base, reacting the phenoxide with dihalogenomethane to give a formaldehyde acetal, intramolecularly oxidatively coupling the formaldehyde acetal to give a cycloheptadiene LANXESS DEUTSCHLAND GMBH (DE) 2002-05-09 US disclosed
EP-1186609-A2 Diphosphines BAYER AG (DE) 2002-03-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030045713-A1 Diphosphines CBR1, SCO2, CCR1 ALDH1A1 1203/4885HSD17B10 3636/4885KDM4E 1653/4885
US-20020055653-A1 Converting a phenol into the corresponding phenoxide using a base, reacting the phenoxide with dihalogenomethane to give a formaldehyde acetal, intramolecularly oxidatively coupling the formaldehyde acetal to give a cycloheptadiene CBR1, PAH, CYP2E1 ALDH1A1 83/4885HSD17B10 675/4885KDM4E 785/4885
US-20030181736-A1 Diphosphines CBR1, SCO2, CCR1 ALDH1A1 1203/4885HSD17B10 3636/4885KDM4E 1653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.